Luye Pharma Group Ltd.
HKEX:2186.HK
Overview | Financials
Company Name | Luye Pharma Group Ltd. |
Symbol | 2186.HK |
Currency | HKD |
Price | 2.95 |
Market Cap | 11,096,926,500 |
Dividend Yield | 0% |
52-week-range | 2.34 - 4 |
Industry | Drug Manufacturers—General |
Sector | Healthcare |
CEO | Mr. Dian Bo Liu |
Website | https://www.luye.cn |
An error occurred while fetching data.
About Luye Pharma Group Ltd.
Luye Pharma Group Ltd., an investment holding company, develops, produces, markets, and sells pharmaceutical products worldwide. The company offers Lipusu for ovarian and breast cancer; CMNa, a chemical sensitizer for cancer radiotherapy; Tiandida for ovarian or non-small cell lung cancer; Boyounuo, an injection for the treatment of various types of
Related Stocks
Financials
Numbers are in millions USD
Numbers are in millions USD